8-K/AOther Events

ABBOTT LABORATORIES 8-K/A Report (Apr 1, 2002)

Filed April 1, 2002For Securities:ABT

Summary

This 8-K filing, an amendment from Abbott Laboratories (ABT) filed on April 1, 2002, primarily announces a significant change in its auditing firm. The Board of Directors, upon recommendation from its Audit Committee, has decided to dismiss Arthur Andersen LLP as its independent public accounting firm. This dismissal is effective upon the engagement of a new auditor or the filing of ABT's Form 10-Q for the period ending March 31, 2002. A new auditor has not yet been appointed. Importantly, the filing states that there were no disagreements with Arthur Andersen on any accounting principles, financial statement disclosures, or auditing procedures during the relevant periods, nor were there any reportable events that would have necessitated a qualified opinion or reference in their audit reports. This suggests a change driven by external factors or strategic decisions rather than audit-related disputes.

Key Highlights

  • 1Abbott Laboratories has decided to dismiss its long-time auditor, Arthur Andersen LLP.
  • 2The dismissal is effective upon the engagement of a new independent public accounting firm or the filing of the Q1 2002 10-Q report.
  • 3A new independent auditor has not yet been appointed.
  • 4There were no disagreements with Arthur Andersen regarding accounting principles or financial disclosures.
  • 5There were no reportable events that would have caused Arthur Andersen to qualify their audit reports.
  • 6Arthur Andersen has agreed with Abbott Laboratories' statements regarding the dismissal.

Frequently Asked Questions

While the filing does not explicitly state the reason for the dismissal, it emphasizes that there were no disagreements on accounting principles or financial disclosures. This suggests the change may be influenced by Arthur Andersen's broader professional circumstances at the time or a strategic decision by Abbott's board and audit committee.

The dismissal of Arthur Andersen will occur on the later of two dates: when Abbott Laboratories engages a new independent public accounting firm, or when Abbott files its quarterly report on Form 10-Q for the period ending March 31, 2002.

No, at the time of this filing, Abbott Laboratories had not yet engaged a new independent public accounting firm to serve as its auditor.

The filing explicitly states that there were no disagreements with Arthur Andersen on any accounting principles, financial statement disclosures, or auditing procedures. Furthermore, Arthur Andersen's reports for 2000 and 2001 did not contain adverse opinions or qualifications. This indicates that the auditor change is not due to any reported issues with Abbott's financial reporting.